How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration
Crossref DOI link: https://doi.org/10.1186/s13023-015-0281-2
Published Online: 2015-06-24
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Furlong, Pat
Bridges, John F. P.
Charnas, Lawrence
Fallon, Justin R.
Fischer, Ryan
Flanigan, Kevin M.
Franson, Timothy R.
Gulati, Neera
McDonald, Craig
Peay, Holly
Sweeney, H. Lee
License valid from 2015-06-24